The largest database of trusted experimental protocols

Female fvbn mice

Manufactured by Charles River Laboratories
Sourced in United States, Montenegro

Female FVBn mice are a widely used mouse strain in biomedical research. They are an inbred strain that is known for its high fertility and large litter sizes. These mice can be used for a variety of studies, including genetic, immunological, and cancer research.

Automatically generated - may contain errors

4 protocols using female fvbn mice

1

FVBn and C57BL/6J Mice Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female FVBn mice (8 weeks old) were obtained from a breeding colony that was generated using mice purchased from Charles River. C57BL/6J wild-type (WT) C57BL/6-Trim21tm1Hm/J (T21−/−) mice were obtained from The Jackson Laboratories. All mice were maintained in a specific pathogen-free environment according to UK Home Office regulations. The experiments involving mice have been approved by the MRC Cambridge Ethical Review Committee and the UK Home Office under project license numbers PPL 70/8087 and PPL PCF3F9520.
+ Open protocol
+ Expand
2

Anti-NKG2D Immunotherapy in KB1P Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female FVB/n mice at 8–10 weeks old (purchased from Charles River) were orthotopically transplanted in their mammary fat pat with 1 × 1 mm tumor pieces from syngeneic K14-Cre;Brca1F/F;Trp53F/F (KB1P) mice. Once tumors reached 1 cm, animals were injected intraperitoneally with a single dose of 200 μg anti-NKG2D (Clone HMG2D, BioXCell) on day 1 followed by individual injections of 100 μg on two consecutive days. Control mice followed the same dosage regime with Armenian hamster IgG isotype control (Clone Polyclonal, Bio X Cell). Tumor growth was measured by calipers and mice were euthanized 1 day after final antibody injection.
+ Open protocol
+ Expand
3

Topical Vemurafenib for Cutaneous Carcinogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female FVB/N mice were purchased from Charles River Laboratory (Wilmington, MA, USA). Tumour induction procedures were carried out in accordance with ARC protocol #2013-066. The two-stage carcinogenesis procedures were performed as described previously24 (link)25 (link) with 8 mice per group. DMBA and TPA were purchased from Sigma. Clinical grade vemurafenib pills were grinded and dissolved in DMSO; to a concentration of 0.02 and 0.04 mg μl−1 and 100 μl of the mixtures (or DMSO as vehicle control) was added topically on the back of the mice. Vemurafenib suspension (2 or 4 mg) or vehicle control was re-applied topically to the back of the mice twice a week for 15 weeks.
+ Open protocol
+ Expand
4

SCID Mice Experiment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Female SCID mice were purchased from the Jackson Laboratory (Bar harbor, ME), female FVB/N mice and BALB/c wild-type mice were purchased from Charles River Laboratories (Wilmington, MA). All the animals used in this study were 8–12 weeks old. At least five mice per experiment were used for this study. Mice were housed in the Kansas City Veteran Administration Medical Center (KCVAMC) animal care facility. Mice were fed commercial mouse diet food (Envigo, Indianapolis, IN) with a 12-hour light-dark cycle under pathogen-free conditions. Experimental animals were carefully monitored throughout the course of the experiment and if they showed signs of distress including, but not limited to, reduced food or water intake, reduced activities, hunched posture, weight loss, vocalization, irritability or lack of grooming, they were euthanized. Euthanasia was performed using CO2 inhalation followed by cervical dislocation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!